| Date |
Title |
Rating |
| 2010-02-27 |
Blacks less likely to know they have atrial fibrillation or about use of warfarin |
None |
| 2010-02-27 |
Single submission of orphan drug designation annual report for both FDA and EMA |
2 |
| 2010-02-27 |
Canada's pharmaceutical products industry stands out strong during recession |
None |
| 2010-02-27 |
Midlothian Laboratories donates more than $3M worth of vitamins, nutritional supplements to AmeriCares |
None |
| 2010-02-27 |
Shire receives marketing approval from FDA for VPRIV |
None |
| 2010-02-27 |
Dabigatran as effective as warfarin in preventing subsequent strokes among atrial fibrillation patients |
5 |
| 2010-02-27 |
Cancer researchers assess PCI-32765 drug that targets molecular abnormalities of lymphoma cells |
None |
| 2010-02-27 |
Prevention of recurrent strokes: Antiplatelet drug cilostazol effective and safer than aspirin |
5 |
| 2010-02-26 |
Gaucher disease: FDA approves VPRIV |
None |
| 2010-02-26 |
Wound Management Technologies announces recent increase in sales of CellerateRx throughout U.S. |
None |
| 2010-02-26 |
Vion Pharmaceuticals' Onrigin SPA: FDA responds |
None |
| 2010-02-26 |
Research and Markets releases 2010 pharmaceutical regulatory report on India |
None |
| 2010-02-26 |
Arena Pharmaceuticals' lorcaserin NDA: FDA assigns PDUFA date |
None |
| 2010-02-26 |
Guidelines and regulations governing orphan drugs in Asia |
None |
| 2010-02-26 |
Overview of pharmaceutical and healthcare industry in China |
None |
| 2010-02-26 |
Pharmaceutical regulations in India: 2010 report |
None |
| 2010-02-26 |
Chinese pharmaceutical and healthcare industry: 2010 regulatory report |
None |
| 2010-02-26 |
Prevention of heart attacks: Resveratrol appears to exhibit broader action than aspirin |
None |
| 2010-02-26 |
Possible damage to children caused by compulsory vaccines: CVS calls for investigation of federal agencies |
None |
| 2010-02-26 |
Rapid, multiplexed genotyping method to identify SNPs that affect warfarin dose developed |
None |
| 2010-02-26 |
Go4Europe conference to focus on current situation of pharmaceutical companies |
None |
| 2010-02-26 |
Study identifies risk factors for vitamin D deficiency in kidney disease patients on dialysis |
None |
| 2010-02-26 |
New dietary supplement blocks triggering mechanism causing breast cell mutations |
None |
| 2010-02-26 |
USPTO issues notice of allowance for Vanda Pharmaceuticals' Fanapt long-acting injectable formulation |
None |
| 2010-02-25 |
Scientists identify new way to treat castrate resistant cells in prostate cancer patients |
2 |
| 2010-02-25 |
E. Fougera receives first generic approval for Imiquimod Cream 5% |
None |
| 2010-02-25 |
FDA sets new PDUFA action date for exenatide once weekly NDA |
None |
| 2010-02-25 |
Sales revenue from Labopharm's once-daily tramadol increases to $4.7M for fourth-quarter fiscal 2009 |
None |
| 2010-02-25 |
Dangers of steroid abuse: Steroids.com gone live |
None |
| 2010-02-25 |
Texas Plant-Expressed Vaccine Consortium announces biotherapeutic manufacturing initiative for infectious diseases |
None |
| 2010-02-25 |
FEHBP's H.R. 4489 overhaul will undermine cost-saving tools and disrupt prescription drug benefits |
None |
| 2010-02-25 |
Myeloma Canada calls on Quebec government to approve Revlimid as second-line therapy |
5 |
| 2010-02-25 |
Texas-based consortium announces biotherapeutic manufacturing initiative for vaccine production |
None |
| 2010-02-25 |
Signaling molecules may link certain actions of B cells to solid tumor growth: Study |
5 |
| 2010-02-25 |
American Lung Association supports ACIP's recommendations for universal influenza immunization |
None |
| 2010-02-25 |
Low doses of lasofoxifene reduce all common problems in postmenopausal women: Study |
None |
| 2010-02-25 |
Orexo partner submits NDA for cancer pain drug Abstral in Japan |
None |
| 2010-02-25 |
Rapamycin may hold promise for Alzheimer's disease |
None |
| 2010-02-25 |
GlaxoSmithKline responds to Staff Report on GlaxoSmithKline and the Diabetes Drug Avandia |
None |
| 2010-02-25 |
New data shows Valortim antibody enhances human T cell response to B. anthracis |
None |
| 2010-02-25 |
Nevirapine taken to protect fetus from HIV should be avoided for one year after childbirth, say researchers |
None |
| 2010-02-25 |
Inverseon comments on LABAs and INV102CR drugs |
None |
| 2010-02-25 |
Advanced ovarian cancer: Avastin-chemotherapy combination followed by Avastin alone improves PFS |
None |
| 2010-02-25 |
High blood pressure drugs may be useful in preventing and treating diabetic retinopathy: Study |
None |
| 2010-02-25 |
EpiCept provides business update and fourth-quarter financial highlights |
None |
| 2010-02-25 |
SSRIs exhibit anti-inflammatory effects and may provide drug development opportunities for RA |
None |
| 2010-02-25 |
Genetic Disorder Tracker introduced by Guidepoint Global |
None |
| 2010-02-25 |
FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine |
None |
| 2010-02-24 |
Unique technology identifies drug candidates, speeds up drug development |
None |
| 2010-02-24 |
FDA approves Wyeth Pharmaceuticals' Prevnar 13 pneumococcal disease vaccine |
None |
| 2010-02-24 |
FDA accepts Arena Pharmaceuticals' lorcaserin NDA |
None |
| 2010-02-24 |
Shire receives FDA Fast Track designation for REPLAGAL |
None |
| 2010-02-24 |
Nutrition 21: Health Canada approves chromium picolinate for sale as a natural health product |
None |
| 2010-02-24 |
FDA's warning over LABA medications for asthma: AANMA offers guidance |
None |
| 2010-02-24 |
PharmAthene awarded total of $78.4M in additional funding to develop SparVax vaccine |
None |
| 2010-02-24 |
ONDCP, HHS announce availability of over $1.1M for new Drug Free Communities Support programs |
4 |
| 2010-02-24 |
Diabetic Neuropathy: Drug having disease-modifying potential will earn 40% patient share in the U.S |
None |
| 2010-02-24 |
Pharmaceutical market in Japan generates total revenues of $65.3 billion in 2008 |
None |
| 2010-02-24 |
Emerging oral atypical antipsychotics to compete in increasingly crowded schizophrenia drug market |
None |
| 2010-02-24 |
Sentry BioPharma Services to warehouse and distribute influenza vaccines for CDC |
None |
| 2010-02-24 |
Joint science advisory issues messages for diabetics at risk for heart disease and stroke |
5 |
| 2010-02-24 |
FEHBP PBM contracts: HR 4489 to reduce fraud and grant OPM greater power to audit |
None |
| 2010-02-24 |
UK pharmacists overwhelmingly prefer dispensing preservative-free drugs |
None |
| 2010-02-24 |
FDA recommends H1N1 for inclusion in next year's flu vaccine |
None |
| 2010-02-24 |
Genetic link between schizophrenia and autism may help study effectiveness of drugs for both illnesses |
None |
| 2010-02-24 |
Poniard Pharmaceuticals enters into $20M committed equity financing facility with Commerce Court Small Cap Value Fund |
None |
| 2010-02-24 |
FDA: Invirase-Norvir combination therapy for HIV may adversely affect the heart |
None |
| 2010-02-24 |
ViiV Healthcare highlights S/GSK1349572, SELZENTRY and EPZICOM for HIV/AIDS at 17th CROI |
5 |
| 2010-02-24 |
Recreational drugs can trigger memory lapse |
None |
| 2010-02-24 |
Prednisolone associated with recurrence of CAP after its withdrawal |
None |
| 2010-02-24 |
WuXi PharmaTech's Shanghai c-GMP manufacturing facility receives MPA compliance certificate |
None |
| 2010-02-24 |
Clout of drug industry seen in MD residency programs and in health reform |
None |
| 2010-02-23 |
Forest Laboratories' Bystolic tablets for treatment of stable CHF failed to receive FDA approval |
None |
| 2010-02-23 |
FDA Gastrointestinal Drugs Advisory Committee supports approval of XIFAXAN 550 mg for management of HE |
4 |
| 2010-02-23 |
NASDAQ halts trading of Salix Pharmaceuticals stock, FDA Committee to discuss XIFAXAN NDA |
None |
| 2010-02-23 |
Health Canada approves GARDASIL for prevention of genital warts in males |
3 |
| 2010-02-23 |
NCC, Pfizer provide over 10M units of ReFacto Antihemophilic Factor to underserved hemophilia patients |
None |
| 2010-02-23 |
Gross sales of Acorda Therapeutics' ZANAFLEX CAPSULES and tablets increase 9.1% to $58.3M in 2009 |
None |
| 2010-02-23 |
Snapshot report of German pharmaceutical market |
None |
| 2010-02-23 |
ExonHit Therapeutics includes proprietary lead compounds into collaboration with Allergan |
None |
| 2010-02-23 |
OTC healthcare market in the Czech Republic increased at 7.3% CAGR between 2003 and 2008 |
None |
| 2010-02-23 |
FDA issues approval for Gileads's Cayston for respiratory symptoms in cystic fibrosis |
None |
| 2010-02-23 |
Obecure granted patent covering betahistine with olanzapine for mitigating antipsychotic drug associated weight gain |
None |
| 2010-02-23 |
Study shows CEL-2000 vaccine blocks RA progression in mice |
None |
| 2010-02-23 |
FDA grants Haemonetics clearance to collect two RBC on Cymbal system |
None |
| 2010-02-23 |
DURECT, Nycomed amend POSIDUR Development and License Agreement |
None |
| 2010-02-23 |
Star Scientific seeks FDA marketing approval for Ariva-BDL dissolvable tobacco lozenge |
5 |
| 2010-02-23 |
Eon Labs to pay $3.5M for resolving False Claims Act allegations concerning Nitroglycerin SR capsules |
5 |
| 2010-02-23 |
Watson Laboratories files ANDA for generic Aplenzin ER in treatment of major depressive disorder |
None |
| 2010-02-23 |
Senate, FDA reports increasing concerns about controversial diabetes drug |
None |
| 2010-02-23 |
AAN guideline evaluates drugs’ safety and efficacy for treatment of muscle cramps |
None |
| 2010-02-22 |
Chiltern International and Charles River Laboratories to study radiolabelled drug products |
None |
| 2010-02-22 |
Ritter Pharmaceuticals to discuss lactose intolerance and associated health risks at NIH Conference |
None |
| 2010-02-22 |
BioSante Pharmaceuticals' ongoing LibiGel Phase III clinical development program: Additional positive data |
None |
| 2010-02-22 |
Gilead Sciences receives FDA approval for new inhaled antibiotic in treatment of CF |
None |
| 2010-02-22 |
Boehringer Ingelheim Pharmaceuticals receives FDA approval for Mirapex ER in treatment of early PD |
None |
| 2010-02-22 |
OTC healthcare market in United Arab Emirates achieved 10% CAGR between 2003 and 2008 |
None |
| 2010-02-22 |
Genetics associated with DILI and SSR: FDA and SAEC complete third release of data |
None |
| 2010-02-22 |
Cancer pain patients: European regulations restricting access to opioid-based drugs |
4 |
| 2010-02-20 |
Missing prescription drugs: Cardinal Health Pharmacy Services to pay $1M penalty |
4 |
| 2010-02-20 |
News outlets examine HIV vaccine research, cervical cancer screening data presented at conference |
None |
| 2010-02-20 |
Amgen's Prolia Complete Response submission: FDA classifies and sets PDUFA date |
None |
| 2010-02-19 |
Janssen-Cilag International's European MAA for ZEFTERA: CHMP adopts negative opinion |
None |
| 2010-02-19 |
Passage of DSSA will restrict Americans’ access to nutritional supplements, says Hotze Enterprises |
5 |
| 2010-02-19 |
GenVec announces new contract with DHS to develop adenovector-based vaccines against FMD |
None |
| 2010-02-19 |
United Therapeutics announces withdrawal of Tyvaso European MAA for treatment of PAH |
None |
| 2010-02-19 |
Depomed receives final meeting minutes from FDA for pre-NDA meeting on DM-1796 for PHN |
None |
| 2010-02-19 |
BioTrends' Stelara second wave report finds increase in prescribing among dermatologists |
None |
| 2010-02-19 |
Parker Waichman Alonso applauds GSK for deciding to stop manufacturing denture adhesive products made with zinc |
None |
| 2010-02-19 |
State policy developments: Wisconsin's new 'public option,' Iowa's medical marijuana vote, and more |
None |
| 2010-02-19 |
Cancer patients frequently face barriers to accessing oral drugs: Study |
None |
| 2010-02-19 |
Delay in Vibativ's approval for nosocomial pneumonia to reduce previously forecasted commercial impact |
None |
| 2010-02-19 |
New Jersey Superior Court links Roche's Accutane to IBD |
5 |
| 2010-02-19 |
DSM Pharmaceutical Products wins Profiles in Sustainability award |
None |
| 2010-02-19 |
Proven strategies mastered by best-in-class biopharma companies |
None |
| 2010-02-19 |
FDA approves 53 new cancer indications between July 2005 and end of 2007 |
None |
| 2010-02-19 |
UBC researcher finds improved uptake of highly active antiretroviral therapy |
None |
| 2010-02-19 |
Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML |
None |
| 2010-02-19 |
Researchers develop technology to preserve vaccines in tropical temperatures |
None |
| 2010-02-19 |
Pharmaceutical and biotechnology companies working on nearly 200 new medicines to treat diabetes |
None |
| 2010-02-19 |
GSK decides to remove potentially hazardous zinc from denture adhesive products |
None |
| 2010-02-19 |
VARI researchers find ways to reverse resistance to sunitinib: Patients with ccRCC show positive response |
None |
| 2010-02-19 |
Valensa International enters into license agreement with Biova for BiovaFlex ingredient |
None |
| 2010-02-19 |
Report examines how medical technology changes state of health care |
None |
| 2010-02-19 |
FDA's proposed label changes for LABA asthma medications: GSK reviews |
None |
| 2010-02-19 |
Asthma: LABAs should not be used alone |
None |
| 2010-02-19 |
FDA accepts filing of Jazz Pharmaceuticals' NDA for sodium oxybate |
None |
| 2010-02-18 |
Lower dose of avosentan drug may provide more favorable results in diabetes patients |
None |
| 2010-02-18 |
FDA approves Rituxan-FC combination therapy for CLL |
None |
| 2010-02-18 |
GeoVax Labs presents results of preclinical study on prototype HIV/AIDS vaccine at CROI |
None |
| 2010-02-18 |
Rituxan, intended for patients with CLL receives FDA approval |
None |
| 2010-02-18 |
OPKO Health acquires Pharmacos Exakta |
None |
| 2010-02-18 |
Medline Industries signs exclusive distribution agreement with Derma Sciences for BIOGUARD Barrier Dressings |
None |
| 2010-02-18 |
NPG becomes official media partner to the 2010 WIN Symposium |
None |
| 2010-02-18 |
Patient-centered medical home concept to benefit pharmaceutical industry |
None |
| 2010-02-18 |
Combination therapy that delays nursing home admission for AD earns 43% patient share in U.S. and 30% in Europe |
None |
| 2010-02-18 |
Catalyst Pharmaceutical Partners to present overview of CPP-115 compound at epilepsy conference |
None |
| 2010-02-18 |
Aptuit develops proprietary production screen to understand API and drug formulations |
None |
| 2010-02-18 |
Study demonstrates once-a-week TB drug is as effective as daily dose |
None |
| 2010-02-18 |
Anti-seizure medication prevents seizures in patients following bleeding stroke: Study |
3.5 |
| 2010-02-18 |
Medication therapy management programs for Aetna Medicare members |
None |
| 2010-02-18 |
Cannabis promising for certain pain-related medical conditions, CMCR presents findings to California legislature |
5 |
| 2010-02-18 |
FDA issues Complete Response Letter for Horizant in treatment of RLS |
None |
| 2010-02-18 |
Taking zinc supplements reduces otitis media in healthy children: No clear evidence |
None |
| 2010-02-18 |
FDA warns about drug mix-ups; drug maker agrees to name change to avoid confusion |
None |
| 2010-02-18 |
Ibuprofen may reduce risk of Parkinson's disease, says study |
None |
| 2010-02-18 |
Media examine fight against counterfeit drugs |
None |
| 2010-02-18 |
Javelin Pharmaceuticals’ Dyloject NDA receives FDA PDUFA date |
None |
| 2010-02-17 |
Sorafenib drug therapy can reduce the size of primary kidney tumors before surgery |
None |
| 2010-02-17 |
Top health groups increased political spending in 2009 |
None |
| 2010-02-17 |
Health Canada approves Talecris Biotherapeutics' PROLASTIN-C for AAT deficiency |
None |
| 2010-02-17 |
IH Systems selects Robotic IV Automation Systems for cytotoxic drug preparation |
None |
| 2010-02-17 |
Pharmatek Laboratories meets DEA requirements for developing and manufacturing controlled substances |
None |
| 2010-02-17 |
Menopause supplement to bring body back into balance |
None |
| 2010-02-17 |
FDA approved cannabis medicines needed for veterans to relieve symptoms of PTSD |
5 |
| 2010-02-17 |
Soligenix' LPM oral drug delivery technology receives Hong Kong patent |
None |
| 2010-02-17 |
Cipher Pharmaceuticals announces fourth-quarter and fiscal year 2009 results |
None |
| 2010-02-17 |
UKONS publishes position statement on safe, effective use of oral anticancer medicines |
None |
| 2010-02-17 |
AHF to protest Merck’s Isentress pricing and policies at CROI |
None |
| 2010-02-17 |
AMAG's Feraheme use on the rise |
None |
| 2010-02-17 |
New book by 12 world-leading scientists calls for renewed approach to drug policy |
None |
| 2010-02-17 |
Belatacept costimulation blocker can prevent rejection of new organs by the immune system |
None |
| 2010-02-17 |
Research suggests scorpion venom could be an alternative to morphine painkiller |
5 |
| 2010-02-17 |
Effectiveness of influenza vaccines in older people: No clear conclusions |
5 |
| 2010-02-17 |
Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine |
None |
| 2010-02-17 |
Researchers use new strategy to develop cancer vaccines |
None |
| 2010-02-17 |
ECR Pharmaceuticals to promote Urocit-K 15mEq tablets to primary care physicians |
None |
| 2010-02-17 |
Covidien's Exalgo NDA: FDA sets new PDUFA action date |
5 |
| 2010-02-17 |
Covidien, IAE POLATOM announce agreement to augment supply of Mo 99 to produce Tc 99m |
None |
| 2010-02-17 |
FDA approves risk management program on ESA's for treating anemia due to chemotherapy |
1 |
| 2010-02-17 |
USPTO issues two new patents for EKR Therapeutics' RTU Cardene I.V. Premixed Injection |
None |
| 2010-02-17 |
AZ&Me Prescription Savings programs help 13% more patients in 2009 |
None |
| 2010-02-17 |
APCER PHARMA to demonstrate pharmacovigilance/drug safety and regulatory services at GPhA meeting |
None |
| 2010-02-17 |
Adding daclizumab to standard treatment reduces enlarged brain lesions in patients with relapsing MS |
None |
| 2010-02-17 |
Combination of daclizumab and interferon beta significantly reduces MS lesion formation |
None |
| 2010-02-17 |
NanoViricides signs research and development agreement with Dr. Eva Harris’s laboratory at UC Berkeley |
None |
| 2010-02-17 |
Bedford Laboratories launches Indomethacin for Injection |
None |
| 2010-02-17 |
CMAJ study: Increased dosage of Tamiflu required in treating H1N1 influenza patients |
None |
| 2010-02-17 |
Amgen and Centocor Ortho Biotech Products: FDA approves REMS for Aranesp, EPOGEN and PROCRIT ESAs |
None |
| 2010-02-17 |
Quark Pharmaceuticals' QPI-1002 receives orphan drug designation from FDA |
None |
| 2010-02-17 |
Embera NeuroTherapeutics establishes clinical development partnership for its cocaine dependence program |
None |
| 2010-02-17 |
TopoTarget pays Celldex Therapeutics $3M sublicense income over Belinostat co-development agreement |
None |
| 2010-02-16 |
FDA extends CombinatoRx' Exalgo tablets NDA PDUFA review date |
None |
| 2010-02-16 |
EntreMed's ENMD-2076 for AML receives FDA's orphan drug designation |
None |
| 2010-02-16 |
BUSACC hosts breakfast panel over reconstruction opportunities in Iraq, covering healthcare and pharma |
None |
| 2010-02-16 |
Sales in oncology supportive care market to drop to $9.3 billion in 2018 |
None |
| 2010-02-16 |
Meda publishes 2009 year-end report |
None |
| 2010-02-16 |
Report on logistics industry in European pharmaceutical market |
None |
| 2010-02-16 |
VPCI pioneers on-demand GMP consultation services for Pharmaceutical manufacturers |
None |
| 2010-02-16 |
Overall benefits of HPV vaccination or frequent screening are low for women over 41 |
None |
| 2010-02-16 |
When blood sugar levels rise in healthy people, insulin signals cells to increase production: Study |
None |
| 2010-02-16 |
AstraZeneca, Rigel Pharmaceuticals announce exclusive worldwide license agreement for R788 |
None |
| 2010-02-16 |
Three Dutch life-science sectors announce joint investment to research on personalized medicine |
None |
| 2010-02-16 |
Use of non-steroidal anti-inflammatory drugs not associated with risk of squamous cell skin cancer |
None |
| 2010-02-16 |
Researchers discover chemical compound to combat malaria and bacterial diseases |
None |
| 2010-02-16 |
Teva Pharmaceuticals USA settles famciclovir patent litigation with Novartis |
None |
| 2010-02-16 |
Albemarle, Pharmacore partner to provide manufacturing capabilities for high volume capacity projects |
None |
| 2010-02-16 |
Sinovac Beijing expands production capacity with acquisition of buildings and land use rights in Changping |
None |
| 2010-02-15 |
Medivir, Meda announce agreement to commercialize Medivir’s cold sore product, Xerese |
None |
| 2010-02-15 |
ERYtech Pharma announces collaborative research agreement with M. D. Anderson Cancer Center |
None |
| 2010-02-15 |
Botulinum injection used for cosmetic purposes may reduce migraine headaches |
None |
| 2010-02-15 |
Research findings may open door to new therapeutic strategies for serious health problems |
None |
| 2010-02-15 |
Isogenica enters into agreement with Dstl to develop antimicrobial peptide drugs |
4 |
| 2010-02-15 |
Walgreens Pharmacies postpones withdrawal from Washington Medicaid program |
None |
| 2010-02-15 |
Antibiotics program of Giant Eagle results in more than $3M in free prescriptions for customers |
None |
| 2010-02-15 |
Wyoming lawkmaker pushes for reform, Mississippi Governor bans certain over-the-counter drugs |
None |
| 2010-02-12 |
U.S. Court rules in favor of Perrigo over Mucinex patent litigation |
5 |
| 2010-02-12 |
Report on wilson disease therapy area drug pipeline |
None |
| 2010-02-12 |
Rate of seasonal flu vaccination doubles national average at Johns Hopkins East Baltimore medical campus |
None |
| 2010-02-12 |
Treating bacteria with insufficient levels of antibiotics leads to multidrug resistance in 'superbugs' |
None |
| 2010-02-12 |
New pain management options for patients undergoing knee or hip replacements |
None |
| 2010-02-12 |
Data demonstrates the effectiveness of NeuroAiD on neuronal and brain injuries |
None |
| 2010-02-12 |
Glycotex announces the expansion of patent portfolio in Advanced Wound Healing for GLYC-101 |
None |
| 2010-02-12 |
Report on sodium borohydride production, consumption and I/E situation in China |
None |
| 2010-02-12 |
Researchers develop dietary supplement to offset key symptom of ageing |
2.5 |
| 2010-02-12 |
Sun Knowledge to attend Annual Drug Benefit Conference in Phoenix |
5 |
| 2010-02-12 |
Low doses of antibiotics may serve as active mutagens and lead to multidrug resistance |
None |
| 2010-02-12 |
Sustamine L-Alanyl-L-Glutamine supplement increases performance in endurance exercise and activity |
None |
| 2010-02-12 |
Proving value a challenge for comparative effectiveness and pharmaceutical technologies |
None |
| 2010-02-12 |
Sales of Cobroxin exceeds XenaCare Holdings' projections for first 45 days of 2010 |
None |
| 2010-02-12 |
Ulcerative colitis drug market to grow up to $2.1 billion in 2018 |
None |
| 2010-02-12 |
Researchers identify potential drug candidate that halts tumor growth |
None |
| 2010-02-12 |
Cancer drug could be effective for treating recurrent nose bleeds |
None |
| 2010-02-12 |
Scientists find single-dose of drug cures visceral leishmaniasis |
None |
| 2010-02-12 |
Biological-based therapies are alternative medicines for women recovering from breast cancer |
None |
| 2010-02-11 |
FDA grants approval for Abbott's antiretroviral medication Norvir |
None |
| 2010-02-11 |
Daiichi Sankyo's Benicar receives FDA approval for hypertension treatment in children and adolescents aged 6-16 |
None |
| 2010-02-11 |
FDA accepts Alexza Pharmaceuticals' AZ-004 NDA |
None |
| 2010-02-11 |
Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter |
None |
| 2010-02-11 |
Analysis of pharmaceutical distribution in Poland |
None |
| 2010-02-11 |
Simcere Pharmaceutical Group subsidiary receives Chinese SFDA approval for Zanamivir |
None |
| 2010-02-11 |
Indiana's pharmaceutical research and manufacturing companies maintained steady growth in 2009 |
None |
| 2010-02-11 |
Micromet outlines the design of registration study for blinatumomab in ALL |
None |
| 2010-02-11 |
Shenogen Pharma Group, Chemizon sign drug discovery collaboration agreement |
None |
| 2010-02-11 |
CINJ researchers develop new vaccine strategy for pancreatic cancer |
None |
| 2010-02-10 |
Drug used to treat parasites in animals may offer new treatment for river blindness, study finds |
None |
| 2010-02-10 |
TZD drug may increase fracture risk in older women |
None |
| 2010-02-10 |
Report on market potential for RNA therapies |
None |
| 2010-02-10 |
Major trends affecting drug discovery market in India and China |
None |
| 2010-02-10 |
AVANIR Pharmaceuticals receives patent for low-dose quinidine formulations of Zenvia to treat PBA |
None |
| 2010-02-10 |
Psoriasis drug Enbrel to account for less than one-fifth of sales in 2018 overall market |
None |
| 2010-02-10 |
Medicinal chemistry paper related to the discovery of CUDC-101 published |
None |
| 2010-02-10 |
Study shows more women die of heart disease each year than men |
None |
| 2010-02-10 |
Majority of parents worry about safety of H1N1 vaccine |
None |
| 2010-02-10 |
Avrio Biopharmaceuticals receives Cal FDB approval to manufacture and ship pharmaceutical products |
None |
| 2010-02-10 |
Biovail and Alexza Pharmaceuticals sign collaboration and license agreement for anti-agitation drug |
None |
| 2010-02-10 |
Glissandra Skincare signs first distribution agreement with Enchanted Meadow |
5 |
| 2010-02-10 |
Report on global acute coronary syndrome disease market |
None |
| 2010-02-10 |
Pivotal Research to study investigational drug for menstrual cramps |
None |
| 2010-02-10 |
New method may help assess impact and cost-effectiveness of flu vaccination campaigns |
None |
| 2010-02-10 |
New research suggests closantel drug may be useful in combating river blindness |
None |
| 2010-02-10 |
Strategic analysis of vitamins and dietary supplements market in the Netherlands |
None |
| 2010-02-10 |
Future studies may provide clarity on the best approach for pre-surgery beta blockers |
None |
| 2010-02-10 |
Breast cancer patients taking antidepressant paroxetine at the same time as tamoxifen are at increased risk of death |
None |
| 2010-02-10 |
Huntington's disease: Latrepirdine appears well-tolerated and beneficial |
1 |
| 2010-02-10 |
VSV has potential to be genetically modified to serve as anti-cancer agent |
5 |
| 2010-02-10 |
Soy isoflavone tablet does not prevent bone loss in postmenopausal women |
None |
| 2010-02-10 |
Antimalarial medicines in African countries are substandard, says QAMSA study |
None |
| 2010-02-10 |
Measles vaccine does not increase risk of autism in children, reveals Polish study |
None |
| 2010-02-10 |
Researchers publish findings that may lead to new standard of care for cervical cancer patients |
None |
| 2010-02-10 |
Cholesterol lowering drugs also reduce risk of developing cataracts |
5 |
| 2010-02-10 |
Dana-Farber Cancer Institute, Sanford-Burnham Medical Research Institute sign license agreement with Genentech, Roche |
None |
| 2010-02-10 |
Findings of poor quality malaria drugs in Africa add to artemisinin-resistance worries |
None |
| 2010-02-10 |
MSU launches research and training program to address product counterfeiting |
None |
| 2010-02-10 |
Research opens door for advancement of new category of painkillers |
None |
| 2010-02-10 |
USPTO awards Transcept Pharmaceuticals patent covering Intermezzo's composition and usage method |
None |
| 2010-02-10 |
GA²LEN and EAACI warn: Older antihistamines in OTC allergy medications may be hazardous |
None |
| 2010-02-10 |
Excelsior Medical receives Canadian marketing license for new, pre-filled catheter lock syringe |
None |
| 2010-02-10 |
FDA expands indication for Crestor |
None |
| 2010-02-09 |
Morphologi G3 adds new dimension to Solvay Pharmaceuticals R&D |
None |
| 2010-02-09 |
Survey reveals need for better access to levalbuterol for asthma patients |
None |
| 2010-02-09 |
Frost & Sullivan's report on rheumatoid arthritis therapeutics market in Thailand |
None |
| 2010-02-09 |
Complete analysis of global macular oedema market |
None |
| 2010-02-09 |
Competitive landscape in global breast cancer market |
None |
| 2010-02-09 |
Regence introduces new solution that covers all medications under single medication benefit |
None |
| 2010-02-09 |
Frost & Sullivan estimates European biomarker analysis market revenues to reach $2202M in 2015 |
None |
| 2010-02-09 |
Cell Therapeutics' pixantrone NDA: FDA postpones ODAC meeting due to severe weather conditions |
None |
| 2010-02-09 |
Merck's asthma drug formoterol/mometasone to garner global peak year sales of more than $250M |
None |
| 2010-02-09 |
FDA accepts Psyadon Pharmaceuticals' ecopipam IND for treatment of LND |
1 |
| 2010-02-09 |
Glaucoma medications appear to reduce mortality risk |
None |
| 2010-02-09 |
Study indicates pain treatment may vary in Latino and white children post surgery |
None |
| 2010-02-09 |
FDA approves Lupin Pharmaceuticals' Amlodipine/Benazepril capsules |
None |
| 2010-02-09 |
FDA approves Sagent Pharmaceuticals' labetalol HCl injection for severe hypertension |
None |
| 2010-02-09 |
Dimebon drug associated with improved cognitive function in patients with Huntington's disease |
None |
| 2010-02-09 |
Kamada commences enrollment in European inhaled AAT clinical trial for alpha-1 antitrypsin deficiency |
4 |
| 2010-02-08 |
Hospitals selling uninsured drugs may negatively impact public system |
None |
| 2010-02-08 |
FDA approves Amneal Pharmaceuticals' Tramadol/APAP tablets |
None |
| 2010-02-08 |
Repros Therapeutics submits Androxal revised indication statement to the FDA |
None |
| 2010-02-08 |
3SBio announces Nephoxil collaboration and license agreement with Panacor Bioscience |
None |
| 2010-02-08 |
LPC Pharma Group outsources pharmacovigilance/drug safety operations to APCER Pharma |
None |
| 2010-02-08 |
Novavax to discontinue collaboration agreement with ROVI Pharmaceuticals |
None |
| 2010-02-08 |
Researchers find low prevalence of tamoxifen use for prevention of breast cancer among women |
None |
| 2010-02-07 |
Investigational drug for osteoporosis inhibits serotonin synthesis in the gut |
5 |
| 2010-02-06 |
URAC seeks public input for Pharmacy Quality Management Accreditation programs |
None |
| 2010-02-06 |
Combination of Motrin and Robitussin drugs is safe for adults and children |
None |
| 2010-02-06 |
HPV vaccination programs may reduce genital diseases |
None |
| 2010-02-06 |
Teva Pharmaceutical Industries reaches settlement in principle to resolve claims under federal, state False Claims Acts |
None |
| 2010-02-06 |
AMAG Pharmaceuticals releases safety update on Feraheme Injection |
None |
| 2010-02-06 |
State policy developments: Iowa seeks to extend birth control coverage; Minn. eyes more health care for poor; Miss. drug settlement |
None |
| 2010-02-06 |
Health bill stall creates uncertainty for drug makers |
None |
| 2010-02-06 |
Strativa Pharmaceuticals' Zuplenz NDA: FDA issues complete response letter |
None |
| 2010-02-05 |
FDA grants Talecris Biotherapeutics orphan drug designation for Alpha1-Proteinase Inhibitor to treat AAT deficiency |
None |
| 2010-02-05 |
BioTime announces results of independent Hextend study in hemodynamically unstable trauma patients |
None |
| 2010-02-05 |
Pharma IQ to organize 4th Improving Solubility conference at The Park Hyatt in Philadelphia |
None |
| 2010-02-05 |
'Doctor Shopping': Data from California's prescription monitoring program |
None |
| 2010-02-05 |
New report on China's pharmaceutical and healthcare market |
None |
| 2010-02-05 |
New ICD-9-CM database provides FDA-approved and off-label uses for therapeutic drugs |
None |
| 2010-02-05 |
Emerson Ecologics officially launches Emerson Quality Program |
None |
| 2010-02-05 |
Complete analysis of China's disposable vaccine syringe industry |
None |
| 2010-02-05 |
Pazopanib drug slows the progression of RCC in patients by 54% |
None |
| 2010-02-05 |
New report finds low adult vaccination rates in U.S. |
None |
| 2010-02-05 |
Mylan first to file ANDA patent for Caduet Tablets |
None |
| 2010-02-05 |
Report shows more Americans are buying prescription drugs to treat digestive conditions |
None |
| 2010-02-05 |
Elephantiasis and river blindness: MSU researcher receives $2M for reformulating flubendazole |
None |
| 2010-02-05 |
New class of compound could become effective antidepressant with minimal side effects |
None |
| 2010-02-05 |
Early stage trial finds malaria vaccine effectively protected young children, study says |
None |
| 2010-02-05 |
Children exposed to acetaminophen prenatally more likely to have asthma symptoms at age five |
None |
| 2010-02-05 |
Pfizer, DxS sign agreement to develop a diagnostic test kit for CDX-110 to treat patients with GBM |
5 |
| 2010-02-05 |
Lux Biosciences seeks US and European marketing approval for LUVENIQ |
None |
| 2010-02-04 |
Progenics Pharmaceuticals to present preclinical data of multiplex PI3K inhibitors |
None |
| 2010-02-04 |
Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin |
None |
| 2010-02-04 |
TenX Biopharma acquires exclusive global rights to zanolimumab from Genmab |
None |
| 2010-02-04 |
Alkermes develops proprietary LinkeRx technology platform to create injectable antipsychotics |
None |
| 2010-02-04 |
"Knowledge deficit" about methadone responsible for resulting deaths |
None |
| 2010-02-04 |
Expert available to discuss Lancet’s retraction of paper on autism study |
None |
| 2010-02-04 |
Phase Forward to participate in DIA Workshop and Clinical Trial Supply event |
None |
| 2010-02-04 |
February issue of Chest releases latest medical news |
None |
| 2010-02-04 |
Discussion on IATA Chapter 17 compliance for temperature-sensitive products at 8th Cold Chain Summit |
None |
| 2010-02-04 |
Health Canada accepts AbstralTM New Drug Submission for review |
None |
| 2010-02-04 |
Paracetamol reduces damage caused to kidneys following severe muscle injury |
1 |
| 2010-02-04 |
Report on Malaysia's pharmaceutical and healthcare market |
None |
| 2010-02-04 |
Providing Tamiflu and educating on sanitizer use helped to stop spread of H1N1 at boys' summer camp |
None |
| 2010-02-04 |
Sermo announces a new report on evolving trends in CML |
None |
| 2010-02-04 |
Viagra promotes fetal growth in pregnant sheep, raises hope for preventing fetal development problems in humans |
None |
| 2010-02-04 |
New discovery lays foundation for development of new anti-HIV drugs |
None |
| 2010-02-04 |
EUCODIS Bioscience to utilize EUR 2M capital injection for adding enzyme families and development of international markets |
None |
| 2010-02-04 |
CRN issues statement on "The Dietary Supplement Safety Act of 2010" |
None |
| 2010-02-04 |
Ipsen launches Decapeptyl LP 22.5 mg in France |
None |
| 2010-02-04 |
Vaccination against seasonal influenza produces protective immune response in infants |
None |
| 2010-02-04 |
FDA approves Xiaflex drug for treatment of Dupuytren's contracture |
3.3 |
| 2010-02-04 |
Study: Generic nifedipine product not bioequivalent to Adalat XL |
5 |
| 2010-02-04 |
National consensus reached on Joint Technical Statement for drug products |
None |
| 2010-02-04 |
Repligen receives USPTO Notice of Allowance for patent covering a recombinant form of Protein A |
None |
| 2010-02-04 |
New vaccine to prevent malaria infection shown promise to protect young children |
None |
| 2010-02-03 |
New York Times examines WHO process for getting H1N1 vaccines to countries in need |
None |
| 2010-02-03 |
Study shows Cymbalta reduces chronic low back pain |
None |
| 2010-02-03 |
FDA approves Labopharm's OLEPTRO antidepressant for MDD |
None |
| 2010-02-03 |
Drug company CEOs under pressure |
None |
| 2010-02-03 |
Adcirca now available in Canada for treatment of pulmonary arterial hypertension |
None |
| 2010-02-03 |
LaGray Chemical receives Frost & Sullivan Ghanaian Pharmaceutical Industry Innovation & Advancement Award |
None |
| 2010-02-03 |
AMPYRA for MS: Acorda Therapeutics announces wholesale pricing and patient assistance program |
5 |
| 2010-02-03 |
Louisiana residents can now save money with free prescription drug cards |
None |
| 2010-02-03 |
New weight-loss supplement burns calories |
None |
| 2010-02-03 |
Research retraction underscores the safety and efficacy of MMR vaccines |
None |
| 2010-02-03 |
Study linking autism and vaccines is retracted by medical journal |
None |
| 2010-02-03 |
Hundred millions for biotech-licence |
None |
| 2010-02-03 |
Hypertension drug market to decrease through 2013 due to generic erosion and few emerging therapies |
1.5 |
| 2010-02-03 |
Tips to prevent heartburn |
None |
| 2010-02-03 |
CPS supports NACI recommendations for new shingles vaccine |
None |
| 2010-02-03 |
BioSpecifics Technologies' XIAFLEX receives FDA approval |
None |
| 2010-02-03 |
Report analyses Japan pharma's current corporate and regulatory environment |
None |
| 2010-02-03 |
PATH to pay FDA $480,000 to speed creation of pneumococcal vaccine for developing world |
None |
| 2010-02-03 |
Upsher-Smith Laboratories introduces new formulation of PreNexa Rx prenatal vitamins |
None |
| 2010-02-03 |
Artefill could be viable for lipoatrophy and non-surgical anti-aging enhancement |
None |
| 2010-02-03 |
VIDAZA prolongs survival in AML patients |
3.9 |
| 2010-02-03 |
Sales of Nutra Pharma's Cobroxin totaled $583,955 for fourth-quarter ending December 31, 2009 |
None |
| 2010-02-02 |
Lannett Company plans to submit NDA for Morphine Sulfate products to FDA |
None |
| 2010-02-02 |
Hovione announces filing of new drug application in Japan for the influenza drug CS-8958 |
None |
| 2010-02-02 |
FDA accepts Teva Pharmaceutical Industries' BLA for XM02 G-CSF |
None |
| 2010-02-02 |
Javelin Pharmaceuticals' NDA for Dyloject Injection accepted for formal review |
5 |
| 2010-02-02 |
FDA approves INNOPHARMA's ibutilide fumarate injection ANDA |
None |
| 2010-02-02 |
Xiaflex receives FDA approval for treatment of Dupuytren's contracture |
5 |
| 2010-02-02 |
FDA approves Taro Pharmaceutical Industries' levetiracetam tablets ANDA |
None |
| 2010-02-02 |
Cytheris broadens patent protection for recombinant human interleukin-7 |
5 |
| 2010-02-02 |
Spectrum Pharmaceuticals signs co-development and commercialization agreement with TopoTarget A/S |
None |
| 2010-02-02 |
FDA requests additional data on CMC section of NDA for taliglucerase alfa from Protalix BioTherapeutics |
None |
| 2010-02-02 |
Extended nicotine patch therapy benefits relapsing smokers trying to quit |
5 |
| 2010-02-02 |
First annual Translational Regenerative Medicine Forum to be held in Winston-Salem |
5 |
| 2010-02-02 |
Global trends in the monoclonal antibody based products market |
None |
| 2010-02-02 |
Suzhou Erye Pharmaceutical receives Chinese SFDA approval for manufacturing penicillin at new facility |
None |
| 2010-02-02 |
New therapeutic made from tobacco plants shown to arrest West Nile virus infection |
None |
| 2010-02-02 |
ADT can worsen heart risk factors and may increase the risk of heart attack |
None |
| 2010-02-02 |
SDI selected for third consecutive time as key monoclonal antibody provider |
None |
| 2010-02-02 |
Kyowa Hakko Kirin enters into distribution agreement with Hisamitsu Pharmaceutical |
None |
| 2010-02-02 |
Decision Resources: Benlysta to garner more than $500M in 2018 |
2 |
| 2010-02-02 |
Some states mull requiring prescription for meth ingredients |
None |
| 2010-02-02 |
BRI partners with French Government to create therapeutic antibodies for treatment of major diseases |
None |
| 2010-02-02 |
FDA and PATH collaborate to advance pneumococcal vaccine development for children |
None |
| 2010-02-02 |
Long-chain omega-3 polyunsaturated fatty acids may reduce risk of psychotic disorders |
None |
| 2010-02-02 |
Serious liver disorder associated with use of HIV drug, FDA warns |
None |
| 2010-02-02 |
Researchers identify antiviral small molecule that is effective against numerous viruses |
None |
| 2010-02-02 |
Evidence suggests antidepressants may improve post-stroke recovery |
None |
| 2010-02-02 |
Shire announces the Canadian availability of VYVANSE prodrug therapy for ADHD treatment |
None |
| 2010-02-01 |
Experimental vaccine reduced TB rate among HIV-positive people in Tanzania, Study finds |
None |
| 2010-02-01 |
TOPICA's IND for onychomycosis antifungal agent accepted by FDA |
None |
| 2010-02-01 |
FDA approves Allergan's JUVÉDERM XC dermal filler |
None |
| 2010-02-01 |
Abbott signs licensing agreement with Pierre Fabre SA to develop and commercialize cancer antibody h224G11 |
None |
| 2010-02-01 |
Ipsen reports consolidated group sales of €1,032.8M for 2009 |
None |